Cetuximab in combination with weekly 5-fluorouracil/folinic acid and oxaliplatin (FUFOX) in untreated patients with advanced colorectal cancer: a phase Ib/II study of the AIO GI Group-Reference-Cited by-同舟云学术

Cetuximab in combination with weekly 5-fluorouracil/folinic acid and oxaliplatin (FUFOX) in untreated patients with advanced colorectal cancer: a phase Ib/II study of the AIO GI Group

Published:2008-08 Issue:8 Volume:19 Page:1442-1449
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Arnold D.,Höhler T.,Dittrich C.,Lordick F.,Seufferlein T.,Riemann J.,Wöll E.,Herrmann T.,Zubel A.,Schmoll H.-J.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/19/8/1442/13780714/mdn150.pdf

Reference35 articles.

1. Global cancer statistics, 2002;Parkin;CA Cancer J Clin,2005

2. Palliative chemotherapy for advanced colorectal cancer: systematic review and meta-analysis. Colorectal Cancer Collaborative Group;Simmonds;BMJ,2000

3. FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomised GERCOR study;Tournigand;J Clin Oncol,2004

4. Phase III study of weekly high-dose infusional fluorouracil plus folinic acid with or without irinotecan in patients with metastatic colorectal cancer: European Organisation for Research and Treatment of Cancer Gastrointestinal Group Study 40986;Kohne;J Clin Oncol,2005

5. Irinotecan or oxaliplatin for first-line treatment of advanced colorectal cancer?;Punt;Ann Oncol,2005

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cetuximab in locally advanced head and neck squamous cell carcinoma: Biological mechanisms involved in efficacy, toxicity and resistance;Critical Reviews in Oncology/Hematology;2021-08

2. Correlation Between the Severity of Cetuximab-Induced Skin Rash and Clinical Outcome for Head and Neck Cancer Patients: The RTOG Experience;International Journal of Radiation Oncology*Biology*Physics;2016-08

3. Targeted Therapy in Solid Tumors: Colorectal Cancer;Targeted Therapy in Translational Cancer Research;2015-10-30

4. Neoadjuvant FOLFOX 4 versus FOLFOX 4 with Cetuximab versus immediate surgery for high-risk stage II and III colon cancers: a multicentre randomised controlled phase II trial – the PRODIGE 22 - ECKINOXE trial;BMC Cancer;2015-07-10

5. A phase I open-label study of the safety, tolerability, and pharmacokinetics of pazopanib in combination with irinotecan and cetuximab for relapsed or refractory metastatic colorectal cancer;Investigational New Drugs;2014-09-24